Vital Therapies reported $108.81M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Enanta Pharmaceuticals ENTA:US USD 321.33M 16.69M
Insmed INSM:US USD -29959000 74.2M
Intercept Pharmaceuticals ICPT:US USD 107.68M 477.51M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Omeros OMER:US USD -46314000 13.61M
Orasure Technologies OSUR:US USD 341.89M 2.3M
Quidel QDEL:US USD 4.8B 124.3M
Regulus Therapeutics RGLS:US USD 39.67M 2.7M
Revance Therapeutics RVNC:US USD 145.71M 148.34M
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
United Therapeutics UTHR:US USD 4.56B 243.8M
Vital Therapies VTL:US USD 108.81M 19.04M
Xoma XOMA:US USD 130.32M 4.63M